Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SECURITY: 6 vs 12 Months DAPT After 2nd Gen DES
NCT00944333Phase 3Terminated
- Sponsor
- Fondazione Evidence per Attività e Ricerche Cardiovascolari
- Start
- Jul 2009
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clopidogrel in angina pectoris, Myocardial ischemia (MI), sponsored by Fondazione Evidence per Attività e Ricerche Cardiovascolari. Started Jul 2009; status: terminated.
02
Drugs
clopidogrel
03
Conditions
angina pectorisMyocardial ischemia (MI)
Beyond the preview
Go deeper on NCT00944333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00944333.